These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 16677860

  • 1. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion.
    Sierra VG.
    Tuberculosis (Edinb); 2006; 86(3-4):169-78. PubMed ID: 16677860
    [Abstract] [Full Text] [Related]

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. New tuberculosis vaccines.
    Martín Montañés C, Gicquel B.
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [Abstract] [Full Text] [Related]

  • 5. Tuberculosis: vaccines in the pipeline.
    Ly LH, McMurray DN.
    Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
    [Abstract] [Full Text] [Related]

  • 6. Prospects for elimination of childhood tuberculosis: the role of new vaccines.
    Hatherill M.
    Arch Dis Child; 2011 Sep; 96(9):851-6. PubMed ID: 21450742
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The tuberculosis vaccine challenge.
    Brennan MJ.
    Tuberculosis (Edinb); 2005 Sep; 85(1-2):7-12. PubMed ID: 15687021
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tuberculosis vaccine.
    Sarhan MA.
    Saudi Med J; 2010 Jan; 31(1):9-13. PubMed ID: 20062891
    [Abstract] [Full Text] [Related]

  • 11. Is intranasal vaccination a feasible solution for tuberculosis?
    Giri PK, Khuller GK.
    Expert Rev Vaccines; 2008 Nov; 7(9):1341-56. PubMed ID: 18980538
    [Abstract] [Full Text] [Related]

  • 12. Childhood tuberculosis: old and new vaccines.
    Hussey G, Hawkridge T, Hanekom W.
    Paediatr Respir Rev; 2007 Jun; 8(2):148-54. PubMed ID: 17574159
    [Abstract] [Full Text] [Related]

  • 13. Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
    Griffin JF, Chinn DN, Rodgers CR, Mackintosh CG.
    Tuberculosis (Edinb); 2001 Jun; 81(1-2):133-9. PubMed ID: 11463234
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM, Bai YL, Shi CH, Gao H, Xue Y, Jiang H, Xu ZK.
    APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
    [Abstract] [Full Text] [Related]

  • 19. Tuberculosis vaccines: past, present and future.
    Martin C.
    Curr Opin Pulm Med; 2006 May; 12(3):186-91. PubMed ID: 16582673
    [Abstract] [Full Text] [Related]

  • 20. Tuberculosis: looking beyond BCG vaccines.
    Mustafa Abu S, Al-Attiyah R.
    J Postgrad Med; 2003 May; 49(2):134-40. PubMed ID: 12867689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.